Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-06 @ 6:45 PM
Study NCT ID:
NCT00110994
Status:
COMPLETED
Last Update Posted:
2015-06-08
First Post:
2005-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2006-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-05-16
First Submit QC Date:
None
Study First Post Date:
2005-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-01-26
Results First Submit QC Date:
None
Results First Post Date:
2011-06-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-13
Last Update Post Date:
2015-06-08
Last Update Post Date Type:
ESTIMATED